Membranoproliferative glomerulonephritis presenting as arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis: A case report

被引:11
|
作者
Park C. [1 ]
Choi S.W. [1 ]
Kim M. [2 ]
Park J. [1 ]
Lee J.S. [1 ]
Chung H.C. [1 ]
机构
[1] Department of Internal Medicine, Ulsan University Hospital, 290-3 Jeonha-dong, Dong-gu, Ulsan
[2] Department of Pathology, Ulsan University Hospital, 290-3 Jeonha-dong, Dong-gu, Ulsan
关键词
Arthropathy; Hypocomplementemic urticarial vasculitis syndrome; Membranoproliferative glomerulonephritis; Valvulopathy;
D O I
10.1186/1752-1947-8-352
中图分类号
学科分类号
摘要
Introduction: Hypocomplementemic urticarial vasculitis syndrome is a rare disorder characterized by chronic urticarial vasculitis, arthralgia, arthritis, and hypocomplementemia. Previously, only six patients with concomitant hypocomplementemic urticarial vasculitis syndrome, Jaccoud's arthropathy, and valvular heart disease have been reported. Case presentation: A 30-year-old Korean man presented with hypocomplementemic urticarial vasculitis syndrome. In addition to urticarial cutaneous lesions, he experienced polyarthralgia and arthritis that resulted in progressive deformity of the joints of both hands, cardiac valvulopathy with mitral, tricuspid, and aortic regurgitation, and intermittent neck swelling with laryngeal edema. He also developed nephritis with azotemia. His renal biopsy results revealed membranoproliferative glomerulonephritis, type I. He showed a partial response to a combination therapy of steroid, cyclophosphamide, and mycophenolate mofetil. Conclusions: We describe, to the best of our knowledge, the first case of glomerulonephritis presenting a arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis syndrome. A combination of corticosteroids, cyclophosphamide, and mycophenolate mofetil appear to be a safe and effective treatment for nephropathy, however are less effective for cutaneous vasculitis, cardiac valvulopathy, and arthropathy. © 2014 Al-Kandari et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [41] Early rehabilitation of a child with intensive care unit acquired weakness secondary to membranoproliferative glomerulonephritis: A case report
    Coskun-Benlidayi, Ilke
    Basaran, Sibel
    Gul-Mert, Gulen
    Guzel, Rengin
    TURKISH JOURNAL OF PEDIATRICS, 2015, 57 (04) : 422 - 425
  • [42] Membranoproliferative glomerulonephritis after intravitreal vascular growth factor inhibitor injections: A case report and review of the literature
    Gan, Grace
    Michel, Mathis
    Max, Antoine
    Sujet-Perone, Nicolas
    Zevering, Yinka
    Vermion, Jean-Charles
    Zaidi, Mohamed
    Savenkoff, Benjamin
    Perone, Jean-Marc
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 401 - 409
  • [43] First Successful Treatment of a Patient with a Primary Immune Complex-Membranoproliferative Glomerulonephritis with Iptacopan: A Case Report
    Arnold, Simone
    Nickler, Manuela
    Dickenmann, Michael
    Menter, Thomas
    Hopfer, Helmut
    Hirt-Minkowski, Patricia
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2024, 14 (01): : 138 - 147
  • [44] Treatment of recurrent, post-kidney transplant membranoproliferative glomerulonephritis with plasmapheresis and rituximab: A case report and literature review
    Yango, Angelito F.
    Fischbach, Bernard V.
    Ruiz, Richard
    Mudrovich, Steven
    Klintmalm, Goran
    CLINICAL NEPHROLOGY, 2019, 91 (01) : 52 - 58
  • [45] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH MULTICENTRIC ANGIOFOLLICULAR LYMPH-NODE HYPERPLASIA - CASE-REPORT AND REVIEW OF THE LITERATURE
    SAID, R
    TARAWNEH, M
    AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (06) : 466 - 470
  • [46] Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis A case report
    Kataoka, Hiroshi
    Mochizuki, Toshio
    Akihisa, Taro
    Kawasoe, Kentaro
    Kawachi, Keiko
    Makabe, Shiho
    Sawada, Anri
    Manabe, Shun
    Sato, Masayo
    Amemiya, Nobuyuki
    Mitobe, Michihiro
    Akanuma, Takafumi
    Ito, Yasuko
    Inoue, Takahiro
    Suzuki, Tomo
    Matsui, Katsuomi
    Moriyama, Takahito
    Horita, Shigeru
    Ohara, Mamiko
    Honda, Kazuho
    Nitta, Kosaku
    MEDICINE, 2019, 98 (02) : E14014
  • [47] Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review
    Leurs, Amelie
    Gnemmi, Viviane
    Lionet, Arnaud
    Renaud, Loic
    Gibier, Jean-Baptiste
    Copin, Marie-Christine
    Hachulla, Eric
    Hatron, Pierre-Yves
    Launay, David
    Fajgenbaum, David
    Terriou, Louis
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [48] Heat-insoluble cryoglobulin in a patient with essential type II cryoglobulinemia and cryoglobulin-occlusive membranoproliferative glomerulonephritis: Case report and literature review
    Meng, Qing H.
    Chibbar, Rajni
    Pearson, Derek
    Kappel, Joanne
    Krahn, John
    CLINICA CHIMICA ACTA, 2009, 406 (1-2) : 170 - 173
  • [49] Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
    Shimada, Michiko
    Nakamura, Norio
    Endo, Tetsu
    Yamabe, Hideaki
    Nakamura, Masayuki
    Murakami, Reiichi
    Narita, Ikuyo
    Tomita, Hirofumi
    BMC NEPHROLOGY, 2017, 18
  • [50] Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report
    Michiko Shimada
    Norio Nakamura
    Tetsu Endo
    Hideaki Yamabe
    Masayuki Nakamura
    Reiichi Murakami
    Ikuyo Narita
    Hirofumi Tomita
    BMC Nephrology, 18